Medicare Patient Access to Cancer Treatment Act

Bill 118 hr 4473, also known as the Medicare Patient Access to Cancer Treatment Act, aims to improve access to cancer treatment for Medicare patients. The bill focuses on addressing the high costs associated with cancer treatment and ensuring that Medicare beneficiaries have affordable access to necessary medications and therapies.

One key provision of the bill is the establishment of a cap on out-of-pocket costs for cancer treatment for Medicare beneficiaries. This cap would limit the amount that patients are required to pay for cancer medications and therapies, helping to alleviate financial burdens and ensure that individuals can access the care they need without facing exorbitant costs.

Additionally, the bill includes measures to increase transparency in pricing for cancer treatments, allowing patients to better understand the costs associated with their care and make informed decisions about their treatment options. This transparency is intended to empower patients to advocate for themselves and seek out more affordable options when necessary. Overall, the Medicare Patient Access to Cancer Treatment Act seeks to improve access to cancer treatment for Medicare beneficiaries by addressing cost barriers and increasing transparency in pricing. By implementing these measures, the bill aims to ensure that individuals with cancer can receive the care they need without facing financial hardship.